Literature DB >> 2686167

Psychotropic medication use during pregnancy.

B H Guze, P A Guze.   

Abstract

Women can have severe and at times life-threatening psychiatric illness during pregnancy. When nonpharmacologic interventions have been attempted and are insufficient, psychotropic medication use is often necessary. The available data on prescription neuroleptic drugs suggest that with the proper selection, use, and supervision, they can be used during pregnancy. The same cannot be said for lithium carbonate or most antidepressants owing to the risks of teratogenicity and toxicity to the fetus. It is prudent to avoid all medication use, if possible, during the first trimester, but deciding how and when to institute treatment depends on an assessment of the risks associated both with the drug and with the untreated illness.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2686167      PMCID: PMC1026861     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  32 in total

1.  EFFECT OF PHENELZINE AND SOME RELATED COMPOUNDS ON PREGNANCY AND ON SEXUAL DEVELOPMENT.

Authors:  E POULSON; J M ROBSON
Journal:  J Endocrinol       Date:  1964-09       Impact factor: 4.286

2.  Occurrence of goitre during lithium treatment.

Authors:  M Schou; A Amdisen; S Eskjaer Jensen; T Olsen
Journal:  Br Med J       Date:  1968-09-21

3.  Placental transfer of chlorpromazine. Case report.

Authors:  J E Hammond; P A Toseland
Journal:  Arch Dis Child       Date:  1970-02       Impact factor: 3.791

4.  Phenothiazine-induced extrapyramidal dysfunction in the neonate.

Authors:  A Tamer; R McKey; D Arias; L Worley; B J Fogel
Journal:  J Pediatr       Date:  1969-09       Impact factor: 4.406

Review 5.  Treatment of mental disorders in pregnancy. A review of psychotropic drug risks and benefits.

Authors:  L L Kerns
Journal:  J Nerv Ment Dis       Date:  1986-11       Impact factor: 2.254

6.  Psychotropics during pregnancy and lactation: a review.

Authors:  J R Calabrese; A D Gulledge
Journal:  Psychosomatics       Date:  1985-05       Impact factor: 2.386

7.  Placental transfer of imipramine, a basic, lipid-soluble drug.

Authors:  B H Douglas; A S Hume
Journal:  Am J Obstet Gynecol       Date:  1967-10-15       Impact factor: 8.661

8.  Extrapyramidal dysfunction in an infant of a schizophrenic mother.

Authors:  R M Hill; M M Desmond; J L Kay
Journal:  J Pediatr       Date:  1966-10       Impact factor: 4.406

9.  Atrial flutter in the newborn resulting from maternal lithium ingestion.

Authors:  N Wilson; J D Forfar; M J Godman
Journal:  Arch Dis Child       Date:  1983-07       Impact factor: 3.791

10.  Lack of relation of oral clefts to diazepam use during pregnancy.

Authors:  L Rosenberg; A A Mitchell; J L Parsells; H Pashayan; C Louik; S Shapiro
Journal:  N Engl J Med       Date:  1983-11-24       Impact factor: 91.245

View more
  4 in total

Review 1.  Effects of antipsychotics on the unborn child: what is known and how should this influence prescribing?

Authors:  H B Pinkofsky
Journal:  Paediatr Drugs       Date:  2000 Mar-Apr       Impact factor: 3.022

2.  Electroconvulsive therapy use during pregnancy.

Authors:  B A Kramer
Journal:  West J Med       Date:  1990-01

Review 3.  Antipsychotic use in pregnancy. What are the best treatment options?

Authors:  M Trixler; T Tényi
Journal:  Drug Saf       Date:  1997-06       Impact factor: 5.606

Review 4.  Use of antipsychotics in the management of schizophrenia during pregnancy.

Authors:  Mátyás Trixler; Agnes Gáti; Sándor Fekete; Tamás Tényi
Journal:  Drugs       Date:  2005       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.